Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Sexually transmitted disease

Chlamydia screening in pharmacies decreases by 7% in 2019 as STI rates rise

Community pharmacies have carried out fewer Chlamydia tests even though overall testing through the National Chlamydia Screening Programme has increased.



Community pharmacies are able to screen for Chlamydia in young people aged 15–24 years through the National Chlamydia Screening Programme

Chlamydia testing in community pharmacies fell by 7% in 2019, despite a 2% overall increase in tests carried out through the National Chlamydia Screening Programme during the same year.

The data, published by Public Healh England (PHE) in ‘Sexually transmitted infections and screening for chlamydia in England, 2019’ on 2 September 2020, also revealed a 5% increase in sexually transmitted infections (STIs) overall.

Community pharmacies are able to screen for Chlamydia in sexually active young people aged 15–24 years through the locally commissioned National Chlamydia Screening Programme, which is also provided by specialist sexual health services, GPs and other healthcare providers.

Overall, 2% more young people were diagnosed with Chlamydia though the programme in 2019 compared with 2018, in line with the 2% increase in testing during that time.

But, according to the data, the number of tests carried out in pharmacies fell from 12,431 in 2018 to 11,598 in 2019. Of these tests, 1,295 patients were diagnosed with Chlamydia in 2019 — a 3% decrease on the year before.

Claire Anderson, chair of the Royal Pharmaceutical Society’s English Pharmacy Board, said community pharmacies are ”well placed to help patients with any questions and issues around sexual health”.

”We want commissioners to consider additional opportunities and clinical services for pharmacy teams, such as appropriate resources and support, so that they can continue to promote good sexual health and help prevent transmission,” she said

In March 2019, PHE similarly advised commissioners to recognise “the value of pharmacy” to provide better sexual health services to patients, adding that Chlamydia screening and treatment, sexual health promotion and providing information on HIV “are not consistently provided across the country”.

Overall, the report highlights a 5% increase in STI diagnoses from 447,522 in 2018 to 468,342 in 2019. This includes a 26% increase in gonorrhoea diagnoses, from 56,232 in 2018 to 70,936 in 2019, and a 10% increase in syphilis diagnoses, with 7,982 cases reported in 2019.

Ian Green, chief executive of Terrence Higgins Trust, said the overall statistics are “heading the wrong way”.

“There was a 2% increase in Chlamydia diagnoses among young people since 2018, despite a 13% decline in the number of tests since 2015. All of this underlines the need for urgent action,” he said

“The government has committed to a national sexual health strategy to improve the nation’s sexual health, which has been delayed by the COVID-19 pandemic. These new figures underline why this can’t be delayed any further — that includes the need for significant investment in public health to ensure sexual health services are accessible as lockdown continues to ease,” he continued.

However, PHE said that the overall rise in STIs is, in part, due to increased testing, more accurate diagnostic tests and “more comprehensive data” on STI diagnoses.

Hamish Mohammed, national lead for sexually transmitted infection surveillance at PHE, warned that gonorrhoea has become more resistant to antibiotics, and that PHE “expects to see further cases of antibiotic-resistant gonorrhoea in the future, which will be challenging for healthcare professionals to manage”.

He added that “consistent and correct use of condoms with new and casual sexual partners is the best defence against all STIs”.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2020.20208323

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • MCQs in Clinical Pharmacy

    MCQs in Clinical Pharmacy

    Four practice tests, each with 80 practice-oriented MCQs. Assess your knowledge of clinical issues, evaluative and analytical skills.

    £25.00Buy now
  • Workplace Drug Testing

    Workplace Drug Testing

    Explains drug testing regulatory frameworks and all aspects of drug analysis. Case studies of successful programmes are included.

    £81.00Buy now
  • Community Pharmacy Handbook

    Community Pharmacy Handbook

    Community Pharmacy Handbook is a survival guide for community pharmacists and students, answering your practical questions. Includes case studies.

    £33.00Buy now
  • Suppositories


    A detailed review of suppository dosage forms. For all those involved in the formulation, development, manufacture and testing of suppositories.

    £71.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.